212 related articles for article (PubMed ID: 15096373)
1. CD30(+) cutaneous lymphoma in association with atopic eczema.
Fletcher CL; Orchard GE; Hubbard V; Whittaker SJ; Edelson RL; Russell-Jones R
Arch Dermatol; 2004 Apr; 140(4):449-54. PubMed ID: 15096373
[TBL] [Abstract][Full Text] [Related]
2. CD56+ lymphoma with skin involvement: clinicopathologic features and classification.
Gniadecki R; Rossen K; Ralfkier E; Thomsen K; Skovgaard GL; Jønsson V
Arch Dermatol; 2004 Apr; 140(4):427-36. PubMed ID: 15096371
[TBL] [Abstract][Full Text] [Related]
3. Aggressive CD30 large cell lymphoma after cyclosporine given for putative atopic dermatitis.
Mougel F; Dalle S; Balme B; Houot R; Thomas L
Dermatology; 2006; 213(3):239-41. PubMed ID: 17033176
[TBL] [Abstract][Full Text] [Related]
4. Lymphomatoid papulosis in a patient with atopic eczema on long-term ciclosporin therapy.
Laube S; Stephens M; Smith AG; Whittaker SJ; Tan BB
Br J Dermatol; 2005 Jun; 152(6):1346-8. PubMed ID: 15949007
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous T-cell lymphoma expressing FOXP3: a case report supporting the existence of malignancies of regulatory T cells.
Marzano AV; Vezzoli P; Fanoni D; Venegoni L; Berti E
J Am Acad Dermatol; 2009 Aug; 61(2):348-55. PubMed ID: 19615546
[TBL] [Abstract][Full Text] [Related]
6. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
7. Pathobiology of CD30+ cutaneous T-cell lymphomas.
Kadin ME
J Cutan Pathol; 2006 Feb; 33 Suppl 1():10-7. PubMed ID: 16412208
[TBL] [Abstract][Full Text] [Related]
8. Pseudocarcinomatous change in lymphomatoid papulosis and primary cutaneous CD30+ lymphoma: a clinicopathologic and immunohistochemical study of 6 patients.
Scarisbrick JJ; Calonje E; Orchard G; Child FJ; Russell-Jones R
J Am Acad Dermatol; 2001 Feb; 44(2):239-47. PubMed ID: 11174381
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
Benner MF; Jansen PM; Meijer CJ; Willemze R
Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous CD30+ anaplastic large cell lymphoma in a heart transplant patient: case report and literature review.
Belloni-Fortina A; Montesco MC; Piaserico S; Bordignon M; Tona F; Feltrin G; Alaibac M
Acta Derm Venereol; 2009; 89(1):74-7. PubMed ID: 19197546
[TBL] [Abstract][Full Text] [Related]
11. Borderline CD30+ cutaneous lymphoproliferative disorder: report of a case with expression of cytotoxic markers and response to clarithromycin.
Ponte P; Serrão V; Viana I; Vale E; João A; Cerroni L
J Cutan Pathol; 2011 Mar; 38(3):301-5. PubMed ID: 19922478
[TBL] [Abstract][Full Text] [Related]
12. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.
Shehan JM; Kalaaji AN; Markovic SN; Ahmed I
J Am Acad Dermatol; 2004 Jul; 51(1):103-10. PubMed ID: 15243534
[TBL] [Abstract][Full Text] [Related]
13. Extracutaneous tumour mass following bexarotene and interferon therapy of primary cutaneous CD30+ large cell lymphoma.
Kreuter A; Altmeyer P; Gambichler T
Acta Derm Venereol; 2006; 86(3):274-5. PubMed ID: 16710601
[No Abstract] [Full Text] [Related]
14. Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature.
Kumar S; Pittaluga S; Raffeld M; Guerrera M; Seibel NL; Jaffe ES
Pediatr Dev Pathol; 2005; 8(1):52-60. PubMed ID: 15719203
[TBL] [Abstract][Full Text] [Related]
15. A case of CD30+ nasal natural killer/T-cell lymphoma.
Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
[TBL] [Abstract][Full Text] [Related]
16. Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome.
Garcia-Herrera A; Colomo L; Camós M; Carreras J; Balague O; Martinez A; Lopéz-Guillermo A; Estrach T; Campo E
J Clin Oncol; 2008 Jul; 26(20):3364-71. PubMed ID: 18541895
[TBL] [Abstract][Full Text] [Related]
17. Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C.
El Shabrawi-Caelen L; Kerl H; Cerroni L
Arch Dermatol; 2004 Apr; 140(4):441-7. PubMed ID: 15096372
[TBL] [Abstract][Full Text] [Related]
18. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
Zoller L; Ramon M; Bergman R
Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous CD30 positive anaplastic large cell lymphoma in an adolescent.
Vaid R; Cohen B
Pediatr Dermatol; 2009; 26(6):721-4. PubMed ID: 20199449
[TBL] [Abstract][Full Text] [Related]
20. Glatiramer acetate-associated, CD30+, primary, cutaneous, anaplastic large-cell lymphoma.
Madray MM; Greene JF; Butler DF
Arch Neurol; 2008 Oct; 65(10):1378-9. PubMed ID: 18852356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
